IREN Limited has recently allocated a substantial compensation package to its co-CEOs, totaling around $800 million. This decision, made on June 30, included the approval of over 18.2 million restricted stock units (RSUs) that were equally divided between William and Daniel Roberts. Each executive will receive approximately 9 million RSUs.
The market reacted negatively, with IREN's shares dropping about 5% in premarket trading on July 2, following a closing price of $43.32 the previous day.
#What Are the Financial Implications of the RSU Grant?
The estimated value of the RSU package sits between $687 million and $800 million, based on share prices fluctuating between $43 and $44. With a vesting and holding schedule of six years extending to fiscal year 2033, these grants account for approximately 17% of IREN’s projected cumulative adjusted net income of $4.7 billion from fiscal years 2027 to 2030. Essentially, for every dollar the company anticipates earning over the next four years, 17 cents is allocated to its two leaders. This significant ratio did not go unnoticed, prompting scrutiny from short-seller Jim Chanos, who criticized the allocation compared to the company's earnings outlook.
The board's decision emerged from what they termed a thorough compensation review involving independent directors and an external consultant.
#How Is IREN Transforming Its Business Model?
IREN is undergoing a major transition from its roots in Bitcoin mining to a robust focus on artificial intelligence (AI) cloud services and high-performance computing (HPC) infrastructure. This strategic shift is backed by substantial contracts and site expansions designed to align with long-term goals. The RSU grants are deliberately linked to this vision, underscoring the six-year timeframe aimed at fiscal year 2033.
#What Should Investors Watch For?
Investors must pay attention to two critical aspects going forward. First, they need to monitor whether IREN's revenue growth in AI and HPC aligns with the company's ambitious $4.7 billion cumulative net income target. Secondly, it is essential to observe if further dilutive grants are issued as the company continues to scale.
These factors could either vindicate the high executive compensation if the projected growth is achieved or raise further concerns if the anticipated performance does not materialize.